|
|
|
Volumn 23, Issue 6 SUPPL. 16, 1996, Pages 42-46
|
|
Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: A Vanderbilt University Cancer Center phase II trial (LUN-46)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
PACLITAXEL;
ADULT;
ADVANCED CANCER;
AGED;
AREA UNDER THE CURVE;
ARTHRALGIA;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
FEMALE;
GRANULOCYTOPENIA;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG CANCER;
MAJOR CLINICAL STUDY;
MALE;
MYALGIA;
NAUSEA;
NEUROPATHY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
VOMITING;
ADULT;
AGED;
AGRANULOCYTOSIS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ARTHRALGIA;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NAUSEA;
NEURALGIA;
PACLITAXEL;
PERIPHERAL NERVOUS SYSTEM DISEASES;
SURVIVAL RATE;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
VOMITING;
|
|
EID: 0030466332
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (9)
|
|
References (17)
|
